The Lancet Respiratory Medicine
ISSN: 2213-2600
eISSN: 2213-2619
Publisher: Elsevier Limited
Publications (4)
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial. (2024)
Meyer S, Bay J, Franz AR, Ehrhardt H, Klein L, Petzinger J, Binder C, et al.
Journal article
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial (2021)
Bauer A, Schreinlechner M, Sappler N, Dolejsi T, Tilg H, Aulinger BA, Weiss G, et al.
Journal article
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial (2021)
Highland KB, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al.
Journal article
Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial (2015)
Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, et al.
Journal article